Summit Therapeutics Inc. ( SMMT) - Key Metrics
SMMT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.28 | -$0.22 | -$0.22 |
| 2026Q1 | $0 | -$0.24 | -$0.12 | -$0.12 |
| 2025Q4 | $0 | -$0.29 | -$0.10 | -$0.10 |
| 2025Q3 | $0 | -$0.31 | -$0.09 | -$0.09 |
| 2025Q2 | $0 | -$0.56 | -$0.07 | -$0.07 |
SMMT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -13.01 |
| 2026Q1 | 0% | -19.75 |
| 2025Q4 | 0% | -15.08 |
| 2025Q3 | 0% | -16.66 |
| 2025Q2 | 0% | -9.50 |
SMMT
Price: $13.35
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 252593
Ebitda: -3.9 millionMarket Capitalization: 12.0 billion